Quantum Biopharma QNTM
NASDAQ QNTM
$3.82 -0.14 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) Research & Development (2020 - 2026)

Updated

Quantum Biopharma's Research & Development was $387,428 in Q2 2026, down 29.5% from $549,197 a year earlier and down 38.1% from the prior quarter.

Analysis

Quantum Biopharma (QNTM) Research & Development (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Quantum Biopharma's Research & Development was $1.58 million through Jun 30, 2026, down 49.1% year-over-year; for FY2025, it was $2.76 million, down 54.6% from FY2024.

  • Research & Development shows a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
  • In earlier years, Research & Development was $6.08 million in FY2024 (+57.6%), $3.86 million in FY2023 (-44.2%), $6.91 million in FY2022 (+9.2%) and $6.33 million in FY2021 (-19.2%).
  • Quarterly Research & Development has moved between -$107,258 (Q3 2021) and $2.69 million (Q4 2022) over five years.
  • Compared with a year earlier, Research & Development has declined for four straight quarters, with growth averaging 109.6% over the last six quarters.
  • The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 928.5%); the worst was Q3 2023 (a decline of 98.2%).
  • Per Business Quant data, QNTM's Research & Development in the three quarters before Q2 2026 was $626,092 (Q1 2026), $70,404 (Q4 2025) and $495,223 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Quantum Biopharma 15.40 Mn 3.20 Mn - 387,428.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 387,428.00
Mar 31, 2026 626,092.00
Dec 31, 2025 70,404.00
Sep 30, 2025 495,223.00
Jun 30, 2025 549,197.00
Mar 31, 2025 1.65 Mn
Dec 31, 2024 160,260.00
Sep 30, 2024 744,802.00
Mar 31, 2024 160,260.00
Dec 31, 2023 1.54 Mn
Sep 30, 2023 32,985.00
Mar 31, 2023 2.31 Mn
Dec 31, 2022 2.69 Mn
Sep 30, 2022 1.87 Mn
Jun 30, 2022 1.41 Mn
Mar 31, 2022 937,052.00
Dec 31, 2021 852,393.00
Sep 30, 2021 -107,258.00
Jun 30, 2021 3.61 Mn
Mar 31, 2021 1.97 Mn
API Access

Quantum Biopharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=QNTM&period=max&api_key=YOUR_API_KEY